Cohen J.M. Bateman B.T. Huybrechts K.F. et al.

Poorly controlled asthma during pregnancy remains common in the United States.

J Allergy Clin Immunol In Pract. 7: 2672-2680. e2610Sawicki E. Stewart K. Wong S. et al.

Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital.

Aust N Z J Obstet Gynaecol. 51: 333-338Rejnö G. Lundholm C. Gong T. et al.

Asthma during pregnancy in a population-based study-pregnancy complications and adverse perinatal outcomes.

PLoS One. 9Kwon H.L. Belanger K. Bracken M.B.

Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys.

Ann Epidemiol. 13: 317-324Hansen C. Joski P. Freiman H. et al.

Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.

Matern child Health J. 17: 1611-1621Wang G. Murphy V.E. Namazy J. et al.

The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis.

J Maternal-Fetal Neonatal Med. 27: 934-942Kim S. Kim J. Park S.Y. et al.

Effect of pregnancy in asthma on health care use and perinatal outcomes.

J Allergy Clin Immunol. 136: 1215-1223. e1216Murphy V. Namazy J. Powell H. et al.

A meta-analysis of adverse perinatal outcomes in women with asthma.

BJOG: An Int J Obstet Gynaecol. 118: 1314-1323

Global Strategy for Asthma Management and Prevention.

Global Initiative for Asthma.

ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy.

Obstet Gynecol. 111: 457-464Al Ghobain M.O. AlNemer M.

Assessment of knowledge and education relating to asthma during pregnancy among women of childbearing age.

Asthma Res Pract. 4: 1-5Powell H. McCaffery K. Murphy V.E. et al.

Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.

J Asthma. 48: 1032-1040

Asthma education and outcomes for women of childbearing age.

Case manager. 14: 58-61Lim A.S. Stewart K. Abramson M.J. et al.

Management of asthma in pregnant women by general practitioners: a cross sectional survey.

BMC Fam Pract. 12: 1-7

Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy.

Reprod Toxicol. 32: 189-197Yland J.J. Bateman B. Huybrechts K.F. et al.

Fetal Outcomes Among Women with Asthma during Pregnancy: Evidence from a Large Healthcare Database in the United States.

J Allergy Clin Immunol. 143: AB422Garne E. Hansen A.V. Morris J. et al.

Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study.

J Allergy Clin Immunol. 136: 1496-1502. e1497

Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.

J Allergy Clin Immunol. 121: 1379-1384. e1371Crane J.P. LeFevre M.L. Winborn R.C. et al.

A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses.

Am J Obstet Gynecol. 171: 392-399

Genetic and epigenetic insights into fetal alcohol spectrum disorders.

Genome Med. 2: 1-8Torfs C.P. Christianson R.E. Iovannisci D.M. et al.

Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis.

Birth Defects Res A: Clin Mol Teratology. 76: 723-730Mossey P.A. Little J. Munger R.G. et al.

Cleft lip and palate.

Lancet. 374: 1773-1785Hyoun S.C. Običan S.G. Scialli A.R.

Teratogen update: methotrexate.

Birth Defects Res Part A: Clin Mol Teratology. 94: 187-207Diav-Citrin O. Shechtman S. Tahover E. et al.

Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.

Am J Psychiatry. 171: 785-794Veroniki A.A. Cogo E. Rios P. et al.

Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.

BMC Med. 15: 1-20Shanks N. Greek R. Greek J.

Are animal models predictive for humans?.

Philos Ethics humanities Med. 4: 1-20

Drugs as teratogens.

CRC press, ClevelandRobijn A.L. Barker D. Gibson P.G. et al.

Factors Associated with Nonadherence to Inhaled Corticosteroids for Asthma During Pregnancy.

The J Allergy Clin Immunol In Pract. 9: 1242-1252. e1241Schatz M. Dombrowski M.P. Wise R. et al.

The relationship of asthma medication use to perinatal outcomes.

J Allergy Clin Immunol. 113: 1040-1045Murphy V.E. Clifton V.L. Gibson P.G.

Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.

Thorax. 61: 169-176Abdullah K. Zhu J. Gershon A. et al.

Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study.

Eur Respir J. 55Breton M.-C. Martel M.-J. Vilain A. et al.

Inhaled corticosteroids during pregnancy: a review of methodologic issues.

Respir Med. 102: 862-875Schatz M. Zeiger R.S. Harden K. et al.

The safety of asthma and allergy medications during pregnancy.

J Allergy Clin Immunol. 100: 301-306Silverman M. Sheffer A. Diaz P.V. et al.

Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide.

Ann Allergy Asthma Immunol. 95: 566-570Bakhireva L.N. Jones K.L. Schatz M. et al.

Asthma medication use in pregnancy and fetal growth.

J Allergy Clin Immunol. 116: 503-509Perlow J.H. Montgomery D. Morgan M.A. et al.

Severity of asthma and perinatal outcome.

Am J Obstet Gynecol. 167: 963-967Alexander S. Dodds L. Armson B.A.

Perinatal outcomes in women with asthma during pregnancy.

Obstet Gynecol. 92: 435-440Dombrowski M.P. Schatz M. Wise R. et al.

Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.

Am J Obstet Gynecol. 190: 737-744Dombrowski M.P. Brown C.L. Berry S.M.

Preliminary experience with triamcinolone acetonide during pregnancy.

J Maternal-Fetal Med. 5: 310-313Källén B. Rydhstroem H. Åberg A.

Congenital malformations after the use of inhaled budesonide in early pregnancy.

Obstet Gynecol. 93: 392-395Källén B. Olausson P.O.

Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications.

Eur J Clin Pharmacol. 63: 363-373Källén B.A. Olausson P.O.

Maternal drug use in early pregnancy and infant cardiovascular defect.

Reprod Toxicol. 17: 255-261Namazy J. Schatz M. Long L. et al.

Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth.

J Allergy Clin Immunol. 113: 427-432Blais L. Beauchesne M.-F. Rey É. et al.

Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.

Thorax. 62: 320-328

Use of drugs during pregnancy—unique Swedish registration method that can be improved.

Inf Swedish Med Prod agency. 1: 8-11Olesen C. Thrane N. Nielsen G.L. et al.

A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes.

Respiration. 68: 256-261Blais L. Beauchesne M.-F. Lemière C. et al.

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations.

J Allergy Clin Immunol. 124: 1229-1234. e1224Norjavaara E. de Verdier M.G.

Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide.

J Allergy Clin Immunol. 111: 736-742

A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.

Curr Med Res Opin. 21: 1075-1084Suissa S. Ernst P. Boivin J.-F. et al.

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Am J Respir Crit Care Med. 149: 604-610Garne E. Vinkel Hansen A. Morris J. et al.

Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy–a cohort linkage study.

BJOG: An Int J Obstet Gynaecol. 123: 1609-1618Eltonsy S. Kettani F.-Z. Blais L.

Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review.

Respir Med. 108: 9-33Cossette B. Beauchesne M.-F. Forget A. et al.

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.

Ann Allergy Asthma Immunol. 112: 459-464Satia I. Cusack R. O’Byrne P.

Paradigm shift in the management of mild asthma: Focus toward a patient centered approach.

Can J Respir Crit Care Sleep Med. 4: 55-60Cusack R.P. Satia I. O’Byrne P.M.

Asthma maintenance and reliever therapy: Should this be the standard of care?.

Ann Allergy Asthma Immunol. 125: 150-155Eltonsy S. Forget A. Beauchesne M.-F. et al.

Risk of congenital malformations for asthmatic pregnant women using a long-acting β2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.

J Allergy Clin Immunol. 135: 123-130. e122Park-Wyllie L. Mazzotta P. Pastuszak A. et al.

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

Teratology. 62: 385-392Skuladottir H. Wilcox A.J. Ma C. et al.

Corticosteroid use and risk of orofacial clefts.

Birth Defects Res Part A: Clin Mol Teratology. 100: 499-506Howley M.M. Papadopoulos E.A. Van Bennekom C.M. et al.

Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997–2011.

J Allergy Clin Immunol In Pract. 8: 3490-3499.e9Blais L. Kettani F.-Z. Forget A. et al.

Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.

Thorax. 70: 647-652

Safety of antileukotriene agents in asthma management.

Ann Allergy Asthma Immunol. 86: 18-23Cavero-Carbonell C. Vinkel-Hansen A. Rabanque-Hernández M.J. et al.

Fetal exposure to montelukast and congenital anomalies: a population based study in Denmark.

Birth defects Res. 109: 452-459Sarkar M. Koren G. Kalra S. et al.

Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.

Eur J Clin Pharmacol. 65: 1259-1264Kim L.H. Saleh C. Whalen-Browne A. et al.

Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.

JAMA. 325: 2466-2479

NAEPP expert panel report: managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update.

J Allergy Clin Immunol. 115: 34-46Weinberger M. Hendeles L.

Theophylline in asthma.

N Engl J Med. 334: 1380-1388

Theophylline.

Am J Of Respir And Crit Care Med. 188: 901-906

Genentech. Xolair (omalizumab): full prescribing information.

() ()Namazy J.A. Blais L. Andrews E.B. et al.

Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.

J Allergy Clin Immunol. 145 (): 528-536Yancey S.W. Keene O.N. Albers F.C. et al.

Biomarkers for severe eosinophilic asthma.

J Allergy Clin Immunol. 140: 1509-1518

Glaxosmithkline. Nucala (mepolizumab): summary of product characteristics. 2021.

Reslizumab (Cinqair): an Interleukin-5 antagonist for severe asthma of the eosinophilic phenotype.

P T. 42: 564 () ()

Regeneron. Dupixent (dupilumab): prescribing information.

() ()Kage P. Simon J. Treudler R.

A case of atopic eczema treated safely with dupilumab during pregnancy and lactation.

J Eur Acad Dermatol Venereol. 34: e256-e257Mian M. Dunlap R. Simpson E.

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report.

JAAD Case Rep. 6: 1051Lobo Y. Lee R.C. Spelman L.

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature.

Case Rep Dermatol. 13: 248-256

European Medicines Agency (EMA): assessment report; dupilumab. 2017.

Knudsen U.B. Hansen V. Juul S. et al.

Prognosis of a new pregnancy following previous spontaneous abortions.

Eur J Obstet Gynecol Reprod Biol. 39: 31-36

Subfertility and risk of spontaneous abortion.

Am J Public Health. 90: 1452

European Medicines Agency (EMA): Summary of product characteristics. 2020.

Cusack R.P. Whetstone C.E. Xie Y. et al.

Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment.

Cells. 10: 817Kabata H. Moro K. Fukunaga K. et al.

Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.

Nat Commun. 4: 1-10

Astrazeneca. Tezspire™(tezepelumab) prescribing information: 2021.

Menzies-Gow A. Corren J. Bourdin A. et al.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

N Engl J Med. 384: 1800-1809Lupattelli A. Spigset O. Twigg M.J. et al.

Medication use in pregnancy: a cross-sectional, multinational web-based study.

BMJ open. 4: e004365